A Study on Alzhemier Disease in Takum, Taraba State, Nigeria: An ARIMA Model Approach
Main Article Content
Abstract
Alzheimer’s disease, a progressive neurodegenerative disorder, represents a significant and growing public health burden, particularly as life expectancy increases worldwide. In sub-Saharan Africa, including Nigeria, the disease's prevalence is rising due to aging populations and urbanized lifestyles that elevate risk factors for cognitive decline. This study investigates the trends and projected incidence of Alzheimer’s disease in Takum, Taraba State, Nigeria. The research utilizes patient records from General Hospital Takum, spanning from 2012 to 2021. Following diagnostic tests and data transformations, the ARIMA(1,2,0) model was selected as the best fit for predicting future case counts. The findings reveal a steady increase in Alzheimer’s cases, consistent with global patterns, highlighting the need for proactive measures in healthcare planning. The study thus recommends the need for increased public awareness, investment in diagnostic infrastructure, and support systems for caregivers.
Downloads
Article Details

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Adeoye, O. A., Ojo, O. A., & Ogunsanwo, O. (2020). Predicting Alzheimer’s Disease Prevalence in Nigeria. Journal of Public Health in Africa, 11(1), 55-62. doi:10.4081/jphia.2020.839.
Alzheimer’s Association. (2023). What is Alzheimer’s Disease?. Retrieved from https://www.alz.org
Bateman, R. J., Xiong, C., Fagan, A. M., et al. (2019). Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease. New England Journal of Medicine, 380(24), 2279-2280. doi:10.1056/NEJMoa1903383.
Chan, C. K., van Hout, H. P., & Hart, D. (2022). Longitudinal Trends in Alzheimer’s Disease Diagnosis. Journal of the American Geriatrics Society, 70(4), 903-912. doi:10.1111/jgs.17657.
Clement A. & Ogunmola A. (2024). Application of ARIMA methods on unemployment and inflation rates in Nigeria. ALSYS, 4(6), 722-741. https://doi.org/10.58578/alsys.v4i6.3580
Jack, C. R., Bennett, D. A., Blennow, K., et al. (2018). The Role of Biomarkers in Alzheimer’s Disease Diagnosis. Nature Reviews Neurology, 14(10), 607-624. doi:10.1038/s41582-018-0060-8.
Jack, C. R., et al. (2018). NIA-AA Research Framework: Toward a Biological Definition of Alzheimer’s Disease. Alzheimer's & Dementia, 14(4), 535–562.
Kandel, M., McCarthy, R., & Ball, H. (2020). Statistical Modeling of Alzheimer’s Disease Incidence. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 16(7), 942-951. doi:10.1002/alz.12115.
Mathew, S., & Idi, D. (2024). Statistical Model for the Occurrence of Typhoid Fever in Takum, Taraba State, Nigeria: An Arima Model Approach. ALSYS, 4(6), 722-741. https://doi.org/10.58578/alsys.v4i6.3580
National Institute on Aging. (2023). Alzheimer's Disease Fact Sheet. Retrieved from https://www.nia.nih.gov
Prince, M., Wimo, A., Guerchet, M., Ali, G.-C., Wu, Y.-T., & Prina, M. (2015). World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International.
World Health Organization. (2023). Dementia and Alzheimer’s Disease Overview. Retrieved from https://www.who.int




















